These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20186552)

  • 1. Interleukin-18 contributes more closely to the progression of diabetic nephropathy than other diabetic complications.
    Fujita T; Ogihara N; Kamura Y; Satomura A; Fuke Y; Shimizu C; Wada Y; Matsumoto K
    Acta Diabetol; 2012 Apr; 49(2):111-7. PubMed ID: 20186552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines.
    Abrahamian H; Endler G; Exner M; Mauler H; Raith M; Endler L; Rumpold H; Gerdov M; Mannhalter C; Prager R; Irsigler K; Wagner OF
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):38-41. PubMed ID: 17286233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
    Elmarakby AA; Sullivan JC
    Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum levels of interleukin-18 in patients with diabetic nephropathy.
    Mahmoud RA; el-Ezz SA; Hegazy AS
    Ital J Biochem; 2004 Jul; 53(2):73-81. PubMed ID: 15646011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Elevated plasma concentration of IP-10 in patients with type 2 diabetes mellitus].
    Xu H; Nakayama K; Ogawa S; Sugiura A; Kato T; Sato T; Sato H; Ito S
    Nihon Jinzo Gakkai Shi; 2005; 47(5):524-30. PubMed ID: 16130407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of IL-18 in type 1 diabetic nephropathy: The problem and future treatment.
    Elsherbiny NM; Al-Gayyar MM
    Cytokine; 2016 May; 81():15-22. PubMed ID: 26836949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microinflammation is a common risk factor for progression of nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.
    Kajitani N; Shikata K; Nakamura A; Nakatou T; Hiramatsu M; Makino H
    Diabetes Res Clin Pract; 2010 May; 88(2):171-6. PubMed ID: 20138680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes.
    Mishra M; Kumar H; Bajpai S; Singh RK; Tripathi K
    Diabetes Res Clin Pract; 2011 Nov; 94(2):255-61. PubMed ID: 21855158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of proinflammatory cytokines in the development and progression of micro- and macroangiopathies in patients with type 2 diabetes mellitus].
    Nelaeva AA; Khasanova IuV; Khobotova ES
    Angiol Sosud Khir; 2013; 19(3):9-13. PubMed ID: 24300485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.
    Mastej K; Adamiec R
    Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association between oxidative stress and IL-6 in NIDDM patients with nephropathy.
    Alsancak S; Aydin M; Yildiz A; Salman S; Seçkin S
    Folia Biol (Praha); 2003; 49(6):235-7. PubMed ID: 14748439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid-binding protein excretion in patients with diabetic nephropathy.
    Nakamura T; Fujiwara N; Sugaya T; Ueda Y; Koide H
    Metabolism; 2009 Aug; 58(8):1185-90. PubMed ID: 19481229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
    Wang QY; Chen FQ
    Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes in patients with end-stage renal disease is not associated with further increased serum inflammatory parameters.
    Bodlaj G; Berg J; Pichler R; Sailer T; Biesenbach G
    J Nephrol; 2004; 17(1):112-7. PubMed ID: 15151267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.
    Xu GW; Yao QH; Weng QF; Su BL; Zhang X; Xiong JH
    J Pharm Biomed Anal; 2004 Sep; 36(1):101-4. PubMed ID: 15351053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy.
    Wong CK; Ho AW; Tong PC; Yeung CY; Kong AP; Lun SW; Chan JC; Lam CW
    Clin Exp Immunol; 2007 Jul; 149(1):123-31. PubMed ID: 17425653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.